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REDUCING BACTERIAL RESISTANCE THROUGH BETTER ANTIBIOTIC 
PRESCRIPTION PRACTICES 
By 
 Christine Ouma,  
A Thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science in Mathematical Sciences with a concentration in Statistics at Virginia 
Commonwealth University. 
 
Virginia Commonwealth University, 2008 
 
 
Major Director: Dr. James E. Mays 
Associate Professor, Department of Statistics and Operations Research 
 
 
The objective of this study was to find a regression procedure that can better 
explain the relationship between patterns of antibiotic use and proportions of bacterial 
resistance. The sample for the study is comprised of 44 University Health System 
Consortium (UHC) member hospitals, and the data for antibiotic use and proportions of 
resistance are from the years 2002 to 2005. The hospitals are spread across the Northeast, 
South, Southwest, Midwest, and Northwest regions of the USA. Based on statistical 
analysis, MRSA continues to have the highest proportion of resistance among the bacteria 
ix 
 
examined and has increased significantly since 2002. The antibiotic use in the study was 
measured in indices called diversity indices.  There were six such measures in the study. 
The study, first using ordinary least squares regression, did not find one single diversity 
index that adequately predicted the proportion of resistance. There were also concerns that 
the diversity indices could be measuring the same thing, and therefore all should not be 
used in the model.  The correlations between the three general diversity indices were 
strong, positive, and linear. Likewise, the three Gram-negative indices were also positively 
correlated with one another. Multicollinearity diagnostics also showed that there were 
serious dependencies among general diversity indices. Given the multicollinearity results 
and the correlation coefficients for the indices, it can be concluded that all six indices 
should not be in the same model together. Logistic regression and weighted least squares 
regression using the logit transformation were also performed, and just like the ordinary 
least squares results, there was no one single diversity index or a combination of diversity 
indices that adequately predicted the proportion of resistance.  
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Chapter 1: Introduction 
 
1.1 Background  
 Bacteria are microorganisms that exist everywhere — from the great outdoors to 
the cleanest of homes. When bacteria get into the body, they can cause illnesses such as ear 
infections, strep throat, food poisoning and pneumonia. The body’s immune system uses 
specially designed cells to locate and shut down microscopic invaders like bacteria, usually 
stopping them before they can cause trouble (Greenwood, 2007). People get sick — what 
is called a bacterial infection — when the bacteria in the body reproduce faster than the 
immune system can kill them. Antibiotics are used to treat bacterial infections. 
 Antibiotics are powerful bacteria killing drugs that help the body fight bacterial 
infection. Today, there are hundreds of antibiotics in use, most tailored to treat a specific 
kind of bacterial infection (Wax, 2008). There are antibiotics meant to kill Gram-negative 
bacteria and those that are meant to kill Gram-positive bacteria. Gram-negative bacteria are 
those bacteria that do not retain crystal violet dye in the Gram staining protocol. Gram-
positive bacteria will retain the crystal violet dye when washed in a decolorizing solution. 
Examples of common Gram-positive bacteria are Staphylococcus aureus and 
Streptococcus cremoris  (Greenwood, 2007).  Gram-negative bacteria include a multitude 
of species like Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, 
Enterobacter cloacae, and Salmonella typhi (Greenwood, 2007). 
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 When the usual antibiotic drugs do not seem to kill the bacteria, such bacteria are 
said to be resistant (Wax, 2008). Bacterial resistance makes an infection much harder to 
treat. Higher doses or stronger drugs may be required. In extreme cases, bacterial 
resistance can be fatal. According to the Centers for Disease Control and Prevention 
(CDC), over prescription and misuse of antibiotic drugs are the main causes of bacterial 
resistance. The CDC says that up to half of the roughly 100 million prescriptions for 
antibiotics written each year are unnecessary. In hospitals, resistance of a given bacteria is 
determined in the laboratory through an antibiogram. An antibiogram is the result of a 
laboratory testing for the sensitivity of an isolated bacterial strain to different antibiotics 
(Estridge, 2008). The proportion of resistant bacteria or isolates is then determined directly 
from the antibiogram by subtracting the percentage of isolates susceptible to the antibiotic 
of interest from one hundred percent and then dividing by one hundred.  
Studies that have been done to examine the link between antibiotic use and 
resistance have traditionally relied upon the proportion of resistant isolates as the outcome 
of interest (Powell, 2007).  A recent study conducted in an academic health-system in 
Brazil found that risk factors for acquiring cephalosporin- or carbapenem-resistant P. 
aeruginosa included exposure to several different antibiotics (Fortaleza et al., 2006).  
Other studies have shown other antibiotics to be predictive of infection with 
fluoroquinolone resistance in P. aeruginosa (Hsu et al., 2005), multi-drug resistant P. 
aeruginosa (Defez et al., 2004), imipenem-resistant A. baumannii (Lee et al., 2004) and 
methicillin-resistant Staphylococcus aureus (MRSA) (MacDougal et al., 2005).     
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Among the differing stewardship strategies being examined is the concept of 
antimicrobial diversity (also referred to as “heterogeneity” or “mixing”).  This strategy 
assumes that bacterial resistance is an evolutionary response to the selective pressure from 
antimicrobial exposure (Powell, 2007).  Diversity of antibacterial drug use is assumed to 
result in a mix of selective pressures on the population of bacteria such that no one 
pathogen is afforded a survival advantage.  A recent survey of 448 hospitals found that a 
lack of diversity of antimicrobial use was significantly associated with higher rates of 
antimicrobial resistance (Zillich, 2006).   
Several methods for quantifying diversity in ecological systems have been 
developed, including Simpson’s Index of Diversity (Simpson, 1949), the Shannon-Weiner 
Index of Diversity (Krebs, 1989), and the Antimicrobial Homogeneity Index 
(Sandiumenge, 2006).   
 
(a) Simpson’s Index of diversity (D) (Simpson, 1949) is given by  
(1 )iD d   and  10  D .   
When D=1, we have maximum diversity and when D=0 there is no 
diversity;      
di  = proportion that the i
th antimicrobial comprises of the total volume of 
antimicrobials considered. 
 
1 { } ( )
2( 1)
i i
n
AHI a b
n
  

  
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(b) The Shannon-Weiner Index of diversity (H) (Krebs, 1989) is given by 
)ln( ii ppH    
where  pi = proportion that the i
th antimicrobial comprises of the total 
antimicrobials considered.   H ranges from 1.5 to 3.5.  
 
(c) The Antimicrobial Homogeneity Index (AHI) (Sandiumenge, 2006) is given by 
 







 )(
)1(2
1 ii ba
n
n
AHI  ,  
where ai = the hypothetical proportion of  antimicrobial i under maximally 
heterogeneous situations, 
bi = the proportion antimicrobial i comprises of the total antimicrobials 
considered, 
n = the total number of antimicrobials considered in the score.   
AHI ranges from 0 to 1. 
 
The ideal method for measuring diversity of antimicrobial use is unknown and 
diversity measures differ on their sensitivity to dominant species (antibacterials) within a 
population.  For instance, it has been noted that Simpson’s Index of diversity is more 
accurate in determining the contribution of more dominant species towards total diversity 
than the Shannon-Wiener Index (Palmer and Young, 2000).  It is unclear which of these 
formulae are best suited for quantifying diversity in terms of antimicrobial use.   
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1.2 Overview of the paper 
 The three indices that are studied in this project are Shannon-Wiener Index 
(SWID), Simpson’s Index of Diversity (SID), and Antimicrobial Homogeneity Index 
(AHI).  Each of the three indices is divided into two categories. The indices derived from 
all the antibiotics are SID, SWID, and AHI, while those derived from antibiotics that treat  
only Gram-negative bacteria are SIDGN, SWIDGN and AHIGN. These six diversity 
indices will be the explanatory variables and the proportions of resistance will be the 
dependent variables. The analysis of the data was done using STATA and SAS software. 
1.3 Literature Review 
Measures of Bacterial Resistance 
 Studies examining the epidemiology of bacterial resistance rely on a number of 
different measures, including the proportion of resistance, the frequency at which the 
bacteria afflict humans, and simply the presence or absence of isolates, to quantify the 
bacterium in question.  A recent article by Schwaber et al. (2004) has cast doubt upon the 
traditional methods of quantifying resistance in the context of multi-hospital epidemiologic 
studies.  The argument that they have put forth is that using the proportion of resistance as 
an outcome variable may not be appropriate for epidemiologists and public health officials 
who are interested in determining the total burden of resistance.  In order to describe 
relationships between resistance and antibacterial usage at this aggregated level, 
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researchers must go beyond the proportion of resistance and conduct analyses using a rate 
of resistance as the outcome of interest (Powell, 2007)   
Prospective Studies 
 There are currently only two published studies that examine the concept of 
antibiotic diversity as an effective stewardship policy for reducing bacterial resistance.  
The first was an investigation examining four different antibiotic use strategies (patient-
specific, prioritization, restriction, and mixing) in a fourteen bed medical/surgical intensive 
care unit from March 2000 through October 2003 (Sandiumenge, 2006).  The study 
examined these strategies in the context of empiric therapy for ventilator-associated 
pneumonia (VAP), which consisted of using the antibiotics anti-pseudomonal 
carbapenems, anti-pseudomonal cephalosporins, and piperacillin-tazobactam.  The use of 
antimicrobials was measured as prescribed daily dose (PDD) per one hundred Intensive 
Care Unit (ICU) stays.  The PDD was defined as the total amount of antibiotic given (in 
grams) divided by the usual dose prescribed in the ICU in a normal patient.  These 
investigators devised a novel index of diversity called the Antibiotic Homogeneity Index 
(AHI) from the Peterson Homogeneity Index to measure the homogeneity of antibiotic use 
during each of the different strategy periods.  Not surprisingly, the mixing period was 
found to have the greatest diversity of empiric drug use (AHI = 0.95).  The authors 
identified in their conclusions that greater antibiotic heterogeneity, either through a patient 
specific or a mixing strategy, appeared to be associated with lower rates of resistant 
bacteria than the lower rates of heterogeneous use associated with cycling strategies. 
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 The second prospective study examining antibiotic diversity was conducted in 
Spanish ICUs from October 2001 to June 2002 (Martinez, 2006).  Martinez and colleagues 
explored the differences of cycling versus mixing strategies also in the setting of empiric 
therapy for VAP.  The antibiotics considered for use were again piperacillin-tazobactam, 
anti-pseudomonal cephalosporins (cefepime and ceftazidime) and anti-pseudomonal 
carbapenems (imipenem and meropenem), but also included ciprofloxacin as an empiric 
choice (whereas the Sandiumenge study only added ciprofloxacin if infection with P. 
aeruginosa was suspected).  The cycling period in this investigation was analogous to the 
prioritization cycling period of the Sandiumenge study.  The authors of this study 
measured antibiotic use as the “mean daily prevalence of use”.  This was calculated by 
dividing the number of patients receiving an antibiotic by the number of patients in the 
ICU for a given day.  While it was assumed that the authors considered a more diverse 
strategy to be one where there was an even proportion of patients receiving each of the four 
empiric antibiotic choices, it is unclear if they used an index of diversity to characterize 
this concept.  Compared to the cycling period, the mixing period was marked by a 
significant increase in the use of anti-pseudomonal carbapemens and piperacillin-
tazobactam coupled with a significant decrease in the use of anti-pseudomonal 
cephalosporins.  Without a traditional measure of diversity, however, it is unclear if this 
resulted in a greater or lesser heterogeneous use of antibiotics than in the cycling period.     
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Chapter 2: Methodology 
 
 This study includes computation of summary statistics for the diversity indices and 
proportions of resistance, linear regression, logistic regression, correlation coefficients 
between the different diversity measures and proportion of resistance, multicolinearity 
diagnostics, residual analysis, and model selection for predicting the proportion of bacterial 
resistance. 
2.1 Introduction of Linear Regression 
Regression analysis refers to a collection of statistical techniques that serve as a 
basis for drawing inferences about relationships among variables. It is assumed that there 
is a functional relationship among variables and the goal is to mathematically model this 
relationship (Myers, 1990). For example, suppose we want to use X1, X2, X3, X4 to predict 
Y. The X variables are referred to as independent (or predictor or regressor) variables, and 
are used to determine or predict Y, called the dependent (or response variable). A suitable 
model is then found to explain the relationship between the X’s and Y. For example, a 
linear regression model is Y = β0+β1X1+ β2X2+β3X3+ β4X4 + ε, where β0 , β1,  β2 , β3, and  
β4  are called regression coefficients or parameters, and ε is the unexplained variability or 
model error. 
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Multiple linear regression model and assumptions 
We have a dependent variable Y and k independent variables X1, X2,…,Xk. There 
are n subjects in the experiment, and for each subject the dependent variable and each of 
the independent variables are measured. The multiple linear regression model is given by  
yi = β0 + β1X1i + β2X2i +…+βkXki+ εi , where i=1, 2, ..., n.  
This model has p=k+1 parameters and is linear in the parameters (Myers, 1990). The data 
of the experiment can be expressed as  
Y X1 X2  … Xk 
y1 x11 x21 … xk1 
y2 x12 x21 … xk2 
. . .  .     
. . .  . 
. . .  . 
yn x1n x2n … xkn 
 
The model can then be written in matrix notation as y=Xβ + ε 
 
 
y=
1
2
.
.
n
y
y
y
 
 
 
 
 
 
 
 
, X=[1, X1, X2,…,Xk]= 
11 21 1
12 22 2
1 2
1 ...
1 ...
. . . .
. . . .
1 ...
k
k
n n kn
x x x
x x x
x x x
 
 
 
 
 
 
 
 
,  β=
0
1
.
.
k



 
 
 
 
 
 
 
 
, and ε=
1
2
.
.
n



 
 
 
 
 
 
 
 
 
The X matrix is referred to as the model or data matrix, and y=Xβ + ε is the general linear 
regression model. 
Multiple linear regression assumptions 
We assume the following for the linear regression model:  
 the Xji are nonrandom and measured with negligible error 
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 E(εi) = 0, implying that the model is appropriate 
 Var(εi) = σ2, implying homogenous variance 
 E(εi εj ) = 0 for i≠j, implying uncorrelated errors. 
It is often assumed the the εi follow a normal distribution in order to make statistical 
inferences from the linear regression model. 
Ordinary least squares 
With the assumptions above, we seek an estimate b of the vector of parameters β 
for which  
2 2
1 1
ˆ( )
n n
i i i
i i
e y y
 
    
is minimized. In multiple regression, the predicted values for the response are  
0 1 1 2 2
ˆ ..i i i k kiy b b x b x b x     , 
so we wish to minimize  
2
0 1 1 2 2
1
( .. )
n
i i i k ki
i
y b b x b x b x

     . 
In matrix notation, we want to find b such that (y-Xb)'(y-Xb) is minimized. To find the 
ordinary least squares estimates, we take partial derivatives of (y-Xb)'(y-Xb) with respect 
to b, set it equal to 0, and solve for b. 

b
 [(y-Xb)'(y-Xb)] = -2X'y + 2(X'X)b = 0 
implies (X'X)b = X'y, which are referred to as normal equations. X is an n x p matrix, with 
n ≥ p. We assume that X is of full column rank [rank(X)=p], implying that the columns are 
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not correlated and X'X is nonsingular. Hence (X'X)-1 exists, and b = (X'X)-1X'y (Myers, 
1990). 
In this project, ordinary least squares multiple linear regression is used to find a 
predictive model for the proportions of resistance with diversity indices as the explanatory 
variables.  
2.2 Introduction of Logistic Regression 
Logistic Regression 
Logistic Regression is a type of regression that involves binary responses (Myers, 
1990). Logistic regression can be used only with two types of dependent variables: 
1.  A categorical response variable that has exactly two categories,  
2. A continuous response variable that has values in the range 0.0 to 1.0 representing 
probability values or proportions. 
The data structure for logistic regression is usually in either grouped or ungrouped form. In 
the ungrouped form, the response variable is denoted by 1 or 0. The grouped data structure 
usually comes from designed experiments where the experimenter can control the X’s. For 
n different combinations of the regressor variables, we record the number ri of successes in 
the ni trials at that level, and then compute the sample proportion of successes ˆ ii
i
r
p
n
 , 
which is taken to be the response (Myers, 1990).   
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Logistic regression estimates are maximum likelihood estimates and depend on the 
data structure. For the ith group we have ni trials and observe ri successes. Hence the 
likelihood function for the ith group is  
 
1 1
( ) 1 ( ) 1
1 1
i i
i i
i i
i i i
i ii
r n r
n rr
n n
P x P x
r r e e


 
  
 
      
      
      
' '
i ix β x β , 
 
 assuming the popular (nonlinear) model of  
 
1
( )
1
i iP x
e


 

'
ix β
 
 
 (Myers, 1990). Here the errors do not have homogenous variance, so ordinary least 
squares is not appropriate for this model, and maximum likelihood estimates are used 
instead. The likelihood function for the entire sample is 
1
1 1
( , ) 1
1 1
i i ir n rn
i
i i
n
L
r e e

 

    
     
     
 ' '
i i
i x β x β
x . 
 
To find maximum likelihood estimates, the natural log of the likelihood function is used, 
which simplifies to  
       
1
ln ( , ) ln ln 1 ln ln 1
n
i
i i i
i i
n
L r e n r e e
r
  

                      

' ' '
i i ix β x β x β
i
x
 
           
1
ln ln 1 ln 1
n
i
i i i
i i
n
r e n r e
r
 

                  

' '
i ix β x β'
i
x β  
         
1
ln ln 1
n
i
i i
i i
n
n e r
r


                 

'
ix β' '
i i
x β x β . 
 
To estimate β, we take derivatives of  ln , ix  with respect to β, and set them equal to 0: 
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Simplifying, the maximum likelihood estimates are solutions ˆ  to the following: 
1 1
1
1
n n
i i
i i
e
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
 

 
 
 
 i i
'
i
'
i
x β
x β
x x
. 
 
There are p (number of parameters in the model) equations with p unknowns, but the 
equations are not linear in β and hence cannot be solved directly. An iterative procedure is 
used to solve for β’s. 
Logit Transformation 
  The logit transformation is a transformation that linearizes the logistic function. 
Starting with the logistic function 
1
( )
1
P
e



'
i
i x β
x , 
 and solving for ix β , we find the logit transformation 
 
( )
ln
1 ( )
P
P
 
 
 
'i
i
i
x
x β
x
. 
Finally, 
( )
ln
1 ( )
P
P
 
 
 
i
i
x
x
 is regressed versus the X’s using weighted least squares. In this 
study the response variable, which is the proportion of resistance, is transformed using the 
logit transformation and then regressed on the diversity indices. 
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2.3 Introduction of Pearson Correlation Coefficient 
A correlation is a statistical measurement for the direction and strength of a linear 
relationship between two variables. This relationship remains linear regardless of the 
measurement scales (Draper and Smith, 1966). Correlation refers to the departure of two 
variables from independence (Miles and Shevlin, 2001). The correlation matrix is a 
symmetric matrix of the pairwise correlation coefficients of several variables (Frank and 
Todeschini, 1994). 
The Pearson correlation coefficient can be obtained by dividing the covariance of 
the two variables by the product of their standard deviations (Myers, 1990). The values for 
sample correlations are known as correlation coefficients and are commonly represented 
by the letter "r". The formula for the correlation coefficient is 
xy
xx yy
S
r
S S
 , 
where  
2
2
2 2 2 1
1 1 1
( )
( )
n
in n n
i
xx i i i
i i i
x
S x X x nX x
n

  
     

   , 
2
2
2 2 2 1
1 1 1
( )
( )
n
in n n
i
yy i i i
i i i
y
S y Y y nY y
n

  
     

   , 
1 1
1 1 1
( )( )
( )( )
n n
i in n n
i i
xy i i i i i i
i i i
x y
S x X y Y x y nXY x y
n
 
  
      
 
   . 
The correlation coefficient ranges between -1 and 1. A positive value for the 
correlation implies a positive association, that is, both variables increase or decrease 
together (large values of X tend to be associated with large values of Y and small values of 
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X tend to be associated with small values of Y). A negative value for the correlation 
suggests a negative or inverse association, that is, as one variable increases, the other 
decreases, and vice versa (large values of X tend to be associated with small values of Y 
and small values of X tend to be associated with large values of Y) (Edwards,1976).  
If r is 1, it implies that all data points fall on a perfect straight line with a positive 
slope as shown in Figure 2.1. This is a perfect linear association (Miles and Shevlin, 2001). 
If r is -1, it implies that all data points fall on a perfect straight line with a negative slope as 
shown in Figure 2.2 (Miles and Shevlin, 2001). 
If the correlation is 0, there is no linear relationship between the variables. An 
example of a plot showing a correlation of 0 is given in Figure 2.3. However, the converse 
is not true because the correlation coefficient detects only linear dependencies between two 
variables (Miles and Shevlin, 2001). 
If r is close to 1, it indicates a strong positive fit. If r is close to -1, it indicates a 
strong negative fit. If r is close to 0, there is a weak linear correlation.  As r increases from 
0 to 1, this displays a moderate to strong positive relationship between the two variables. 
As r decreases from 0 to -1, this displays a moderate to strong negative relationship 
between the two variables. Some of the analyses in this paper also report the coefficient of 
determination, R2 (=r2), which measures the proportion of the variation of one variable that 
is predictable from the other variable. 
In this project, Pearson correlation coefficients are used to measure the strength of 
a linear relationship between the proportion of resistance and diversity indices, and 
between each pair of diversity indices. 
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Figure 2.1: Scatterplot showing r=1 
Y
X  
Figure 2.2: Scatterplot showing r=-1 
Y 
X  
Figure 2.3: Scatterplot showing r=0 
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2.4 Introduction of Multicollinearity 
Multicollinearity 
  Multicollinearity is a linear association among the regressor variables and exists 
when two or more regressors have high empirical correlations. To identify possible linear 
dependencies among regressors included in the model, various measures of the degree of 
multicollinearity are obtained.  These include variance inflation factors (VIFs), Condition 
Index (CI), and Variance Decomposition proportions associated with the eigenvalues.  
 The variance inflation factor is the most common measure of multicollinearity. If 
2
iR  is the coefficient of determination resulting when the predictor variable Xi is regressed 
on all the remaining predictor variables, the variance inflation factor for Xi (VIFi) is given 
by 
2
1
(1 )
i
i
VIF
R


. 
The VIFs for ordinary least squares are the diagonal elements of the inverse of the 
simple correlation matrix. The VIFs indicate the inflation in the variance of each regression 
coefficient compared with a situation of orthogonality. The decision to consider a VIF to be 
large is essentially arbitrary. Usually, values larger than 10 suggest that multicollinearity 
may be causing estimation problems (Myers, 1990). 
  In the presence of multicollinearity, the determinant of the correlation matrix 
among predictor variables is very small. Because the determinant also is equal to the 
product of eigenvalues i, the presence of one or more small eigenvalues results in a small 
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determinant, thereby indicating multicollinearity. A measure of multicollinearity, called the 
condition index (CI) is obtained for each eigenvalue by computing:  
max
i
i
CI


  
where max is the largest eigenvalue, and i is the ith eigenvalue of the correlation matrix. 
Large CIi indicates dependencies
 among covariates because i will be close to zero. Belsley 
(1991) suggested that a CI between 10 and 30 would indicate possible problems of 
multicollinearity, and a CI larger than 30 suggests the presence of multicollinearity.  
  Variance decomposition proportions associated with the eigenvalues indicate 
variables that are involved in linear dependencies, and how much of the variance of the 
parameter estimate is associated with each eigenvalue. Following Belsley (1991), 
2 1 2ˆ ˆVar( ) ( )    -1b X X VΛ V  
where 2ˆ is the residual variance estimate, V is a matrix containing the eigenvectors of 
X́X, and  is a diagonal matrix of eigenvalues of X́X (i.e., diag ( 1 2 . . . k)). Here X 
represents the centered and scaled matrix of regressors. Writing V = vij, the variance of the 
ith element of b, the vector of regression coefficients, can be decomposed into a sum of k 
components, each associated with one eigenvalue, as follows:  
2
2
1
ˆ( )
k
ij
i
j j
v
Var b 

   
where k is the number of predictor variables. Because eigenvalues appear in the 
denominator, variance components associated with dependencies (small j) will be 
relatively large compared to the other components. Thus, a high proportion of two or more 
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coefficients associated with the same small eigenvalue provide evidence that the 
corresponding dependencies are causing problems.  Let   
2
ij
ij
j
v
t

   ,  and 
1
k
i ijj
t t

 , with i=1, ..., k. 
 Then the proportion of the variance of the ith regression coefficient associated with the jth 
component of its decomposition is obtained as follows:  
ij
ji
i
t
t
   with  i, j = 1, ..., k. 
2.5 Introduction of Model Selection 
 Variable selection is used to find the smallest, most economical, set of variables 
needed for estimating the dependent variable. The model selection criteria used in this 
study are R-square and adjusted R-square, stepwise method, forward selection, and 
backward elimination. 
 Forward selection begins by finding the variable that produces the optimum one-
variable model. In the second step, the procedure finds the variable that, when added to the 
already chosen variable, results in the largest significant reduction in the residual sum of 
squares (largest increase in R2). The third step finds the variable that, when added to the 
two already chosen, gives the largest significant reduction in residual sum of squares 
(maximum R2). The process continues until no variable considered for addition to the 
model provides a reduction in sum of squares considered statistically significant at a level 
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specified by the user. An important feature of this method is that once a variable has been 
selected, it stays in the model. 
 Backward elimination begins by computing the regression with all independent 
variables included in the model. The procedure deletes from the model the variable whose 
coefficient has the largest insignificant p-value (smallest partial F value). The resulting 
equation is examined for the variable now contributing the least, which is then deleted, and 
so on. The procedure stops when all coefficients remaining in the model are statistically 
significant at a level specified by the user. With this method, once a variable has been 
deleted, it is deleted permanently. 
 The stepwise method begins like forward selection, but after a variable has been 
added to the model, the resulting equation is examined to see if any coefficient has a 
sufficiently large p-value to suggest that a variable should be dropped. Once all 
insignificant variables have been dropped, the remaining variable with the lowest 
significant p-value is added to the model and then all variables in the model are tested to 
see if any should be removed. This procedure continues until no additions or deletions are 
indicated according to the significance level chosen by the user. 
2.6 Introduction of Residual Analysis 
 Analysis of the residuals, ei = yi - ŷi, can be used to inspect the adequacy of the 
model and any possible violations of assumptions. One way to do this is to inspect a plot of 
the residuals versus the independent variable values (xi) or versus the predicted values (ŷi). 
If the model is appropriate, a plot of residuals versus xi should be centered at 0 and 
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scattered about the line at 0. The absolute residuals should be close to 0, with what is 
considered “small” depending on the size of the residuals when compared to the observed 
Y data. The assumptions for ordinary least squares, which include normally distributed 
errors and homogenous variance, should be checked. The residuals also provide a check of 
whether or not the proper structure has been chosen for the model (including linear versus 
nonlinear).
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Chapter 3: Descriptive Statistics 
 
 
List of bacteria in the Study 
CERKS: cephalosporin-resistant Klebsiella species 
CERES: cephalosporin-resistant Enterobacter species 
FQREC: fluoroquinolone-resistant Escherichia coli 
MRSA: methicillin-resistant Staphylococcus aureus 
CERPA: cephalosporin-resistant Pseudomonas aeruginosa 
CPRPA: carbapenem-resistant Pseudomonas aeruginosa  
FQRPA: fluoroquinolone-resistant Pseudomonas aeruginosa 
PTRPA: piperacillin-tazobactam-resistant Pseudomonas aeruginosa 
 
List of indices in the Study 
SID: The Simpson’s Index of diversity  
SIDGN: The Simpson’s Index of diversity Gram Negative 
SWID: Shannon-Weiner Index of diversity   
SWIDGN: Shannon-Weiner Index of diversity Gram Negative 
AHI: Antimicrobial Homogeneity Index 
AHIGN: Antimicrobial Homogeneity Index Gram Negative 
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3.1 Descriptive Statistics of Proportion of Resistance  
The number of observations varied throughout the study period depending on the 
number of health-systems that agreed to participate and the number of antibiograms that 
were submitted during a given year.  The overall mean trends of resistant bacteria in 
hospitals for which we could calculate proportions for all four years in the study period are 
depicted in Figure 3.1. Descriptive statistics (mean, median, standard deviation, maximum, 
and minimum) are shown in Table 3.1. As depicted in the graph, MRSA proportions of 
resistant isolates were the highest while CERKS proportions of resistant isolates were the 
lowest. 
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Figure 3.1  Trends in mean proportions of resistant bacteria from 2002-2005 
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Table 3.1:  Descriptive statistics for proportions of resistant isolates from 2002-2005 
Bug-Year n mean median stdev min max 
CERES-2002 21 0.28 0.28 0.115 0.12 0.66 
CERKS-2002 21 0.06 0.03 0.076 0.00 0.26 
CERPA-2002 21 0.21 0.18 0.116 0.04 0.44 
CPRPA-2002 27 0.19 0.18 0.084 0.04 0.42 
FQREC-2002 23 0.08 0.07 0.055 0.00 0.19 
FQRPA-2002 31 0.35 0.36 0.103 0.16 0.54 
MRSA-2002 31 0.43 0.45 0.103 0.19 0.64 
PTRPA-2002 27 0.12 0.12 0.052 0.04 0.26 
CERES-2003 23 0.28 0.25 0.105 0.14 0.54 
CERKS-2003 23 0.05 0.03 0.063 0.00 0.26 
CERPA-2003 23 0.22 0.21 0.101 0.05 0.41 
CPRPA-2003 32 0.21 0.21 0.081 0.05 0.39 
FQREC-2003 25 0.11 0.09 0.062 0.02 0.28 
FQRPA-2003 32 0.36 0.38 0.097 0.14 0.51 
MRSA-2003 33 0.49 0.49 0.099 0.28 0.71 
PTRPA-2003 30 0.15 0.14 0.066 0.03 0.29 
CERES-2004 23 0.29 0.30 0.095 0.13 0.51 
CERKS-2004 24 0.09 0.04 0.126 0.00 0.41 
CERPA-2004 24 0.22 0.21 0.093 0.08 0.41 
CPRPA-2004 31 0.20 0.20 0.099 0.05 0.48 
FQREC-2004 25 0.14 0.11 0.083 0.03 0.34 
FQRPA-2004 32 0.36 0.36 0.101 0.15 0.52 
MRSA-2004 33 0.52 0.51 0.097 0.30 0.71 
PTRPA-2004 29 0.14 0.14 0.068 0.04 0.31 
CERES-2005 20 0.25 0.22 0.140 0.04 0.64 
CERKS-2005 24 0.12 0.06 0.200 0.01 1.00 
CERPA-2005 24 0.22 0.21 0.095 0.05 0.43 
CPRPA-2005 24 0.23 0.22 0.126 0.06 0.60 
FQREC-2005 24 0.17 0.15 0.096 0.00 0.39 
FQRPA-2005 25 0.34 0.36 0.106 0.10 0.58 
MRSA-2005 25 0.54 0.53 0.142 0.36 0.98 
PTRPA-2005 25 0.13 0.11 0.072 0.01 0.33 
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MRSA: methicillin-resistant Staphylococcus aureus     
The median proportion of MRSA isolates increased steadily from 2002 to 2005 as 
shown in Figure 3.2.  The box plots show that there were three outliers in 2002, and one 
outlier for each of the other three years. 
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Figure 3.2 Trend in median proportion and Box plots from 2002-2005 for MRSA  
 
CERPA: cephalosporin-resistant Pseudomonas aeruginosa 
The median proportions of CERPA isolates increased steadily from 2002 to 2003 
then leveled in the subsequent years as shown in Figure 3.3.  The box plots show near 
symmetrical distributions for each of the four years that the study covered. 
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Figure 3.3.  Trends in median proportions and Box plots from 2002-2005 for CERPA 
 
CERES: cephalosporin-resistant Enterobacter species 
The median proportion of CERES decreased from 2002 to 2003, increased in 2004, 
and decreased again in 2005 as shown in Figure 3.4. The box plots show an outlier 
observation in 2002. The variation in proportion of resistance was highest in 2005. 
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Figure 3.4.  Trends in median proportions and Box plots from 2002-2005 for CERES  
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CERKS: cephalosporin-resistant Klebsiella species 
 The median proportion of CERKS in 2002 was similar to that of 2003 and 
increased in subsequent years as shown in Figure 3.5. The box plots show presence of 
outliers in each of the four years. 
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Figure 3.5.  Trends in median proportions and Box plots from 2002-2005 for CERKS  
 
CPRPA: carbapenem-resistant Pseudomonas aeruginosa  
 The median proportion for CERPA remained below 0.25 during the study period. 
There was a slight increase in proportion of CERPA from 2002 to 2005 as shown in Figure 
3.6. Without the outliers, the distributions for 2002, 2004, and 2005 look symmetrical.  
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Figure 3.6.  Trends in median proportions and Box plots from 2002-2005 for CPRPA 
   
FQREC: fluoroquinolone-resistant Escherichia coli;  
 The median proportion of FQREC increased steadily from 2002 to 2005 as shown 
in Figure 3.7 . The box plots show presence of outliers for the years 2003 and 2004. 
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Figure 3.7.  Trends in median proportions and Box plots from 2002-2005 for FQREC  
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FQRPA: fluoroquinolone-resistant Pseudomonas aeruginosa 
The median proportion of FQRPA increased from 2002 to 2003, then decreased 
from 2003 to 2004, and finally leveled off as shown in Figure 3.8. The box plots for each 
of the four years show symmetrical distributions for the four years, with two outliers in 
2005. 
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Figure 3.8.  Trends in median proportions and Box plots from 2002-2005 for FQRPA  
 
PTRPA: piperacillin-tazobactam-resistant Pseudomonas aeruginosa: 
The median proportion of PTRPA remained low during the study period with a 
slight increase between 2002 and 2003, and then decreased between 2004 and 2005. The 
distribution for 2005 is heavily positively skewed with one outlier as shown in Figure 3.9. 
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Figure 3.9  Trends in median proportions and Box plots from 2002-2005 for PTRPA  
 
 
The hospitals that show up as outliers in the proportion of resistance box plots are 
Nevada, RW Johnson, Penn state, The Methodist Hospital, and Ohio State-East. They have 
proportions of resistance that are higher than the rest of the hospitals. Since most of these 
outliers are showing high proportions of resistance, one would expect the diversity indices 
associated with these outlier hospitals to be lower than the rest of the hospitals, but this is 
not the case. Table 3.2 shows the mean and median of diversity indices of the outlier 
hospitals and the mean and the median diversity indices for the rest of the hospitals. 
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Table 3.2:  Median and mean of the diversity indices for outliers 
 
Index-Year 
Mean of 
outliers  
Median of 
outliers 
Mean 
without 
outliers  
Median 
without 
outliers  
SID-2002 0.86 0.87 0.87 0.88 
SID-2003 0.86 0.87 0.88 0.88 
SID-2004 0.87 0.87 0.88 0.88 
SID-2005 0.88 0.87 0.88 0.88 
SWID-2002 2.21 2.22 2.25 2.27 
SWID-2003 2.21 2.23 2.26 2.27 
SWID-2004 2.24 2.23 2.27 2.29 
SWID-2005 2.26 2.25 2.26 2.28 
AHI-2002 0.61 0.62 0.63 0.64 
AHI-2003 0.59 0.58 0.62 0.62 
AHI-2004 0.59 0.58 0.62 0.63 
AHI-2005 0.61 0.59 0.64 0.65 
 
 
3.2 Descriptive Statistics for the Diversity Indices 
The number of diversity indices also varied throughout the study period depending 
on the number of health-systems that agreed to participate and number of antibiograms that 
were submitted during a given year.  The descriptive statistics (mean, median, standard 
deviation, maximum, and minimum) for the six diversity indices are shown in Table 3.3. It 
is clear from these summary statistics that the values for each index have been very 
consistent across the years. 
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Table 3.3: Descriptive Statistics for Diversity Indices 
Index-Year n mean median stdev min max 
SID-2002 31 0.87 0.87 0.014 0.84 0.90 
SID-2003 35 0.87 0.88 0.013 0.84 0.89 
SID-2004 38 0.88 0.88 0.012 0.84 0.90 
SID-2005 37 0.88 0.88 0.014 0.82 0.89 
SIDGN-2002 31 0.59 0.60 0.071 0.39 0.68 
SIDGN-2003 35 0.61 0.62 0.057 0.41 0.68 
SIDGN-2004 38 0.61 0.62 0.069 0.34 0.70 
SIDGN-2005 37 0.62 0.63 0.066 0.36 0.71 
SWID-2002 31 2.25 2.26 0.077 2.07 2.42 
SWID-2003 35 2.26 2.27 0.070 2.06 2.35 
SWID-2004 38 2.26 2.27 0.068 2.07 2.38 
SWID-2005 37 2.26 2.28 0.075 2.01 2.37 
SWIDGN-2002 31 1.08 1.10 0.132 0.67 1.26 
SWIDGN-2003 35 1.11 1.12 0.105 0.72 1.23 
SWIDGN-2004 38 1.11 1.14 0.129 0.63 1.29 
SWIDGN-2005 37 1.12 1.13 0.122 0.72 1.32 
AHI-2002 31 0.64 0.63 0.046 0.53 0.74 
AHI-2003 35 0.62 0.62 0.042 0.50 0.69 
AHI-2004 38 0.62 0.63 0.044 0.49 0.68 
AHI-2005 37 0.62 0.63 0.045 0.51 0.70 
AHIGN-2002 31 0.61 0.62 0.091 0.39 0.75 
AHIGN-2003 35 0.63 0.64 0.067 0.44 0.73 
AHIGN-2004 38 0.63 0.65 0.093 0.25 0.77 
AHIGN-2005 37 0.64 0.64 0.087 0.38 0.82 
 
3.3 Box Plots for the Diversity Indices 
 Box plots were constructed to graphically summarize and display the data for all 
six diversity indices for the years 2002-2005. For SID in Figure 3.10, the datasets for the 
years 2002, 2003, 2004, and 2005 are all skewed to the left due an outlier present in each.  
The dataset for 2002 would be symmetrical without the outlier. The median value, lower 
quartile, and upper quartile do not vary much across the years.  
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Figure 3.10: Box plots of Simpson’s Index of diversity 2002-2005 
 
 
SIDGN data sets for all four years are skewed to the left due to the presence of outliers as 
shown in Figure 3.11. Year 2005 has three outliers, 2003 and 2004 have two outliers each, 
and 2002 has one outlier. 
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Figure 3.11 Box plots of Simpson’s Index of diversity Gram Negative 2002-2005 
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SWID data sets for all four years are negatively skewed due to the presence of outliers, as 
seen in Figure 3.12.   
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Figure 3.12: Box plots of Shannon-Weiner Index of diversity 2002-2005 
 
SWIDGN data sets for all four years are negatively skewed due to the presence of outliers 
as shown in Figure 3.13.  
 
 
0.6 
0.8 
1.0 
1.2 
1.4 
2002 2003 
2004 2005 
 
 
Figure 3.13: Box plots of Shannon-Weiner Index of diversity Gram Negative 2002-
2005 
 
As seen in Figure 3.14, the AHI distribution for 2002 is positively skewed and for 2005 is 
negatively skewed, while those for 2003 and 2004 are nearly symmetrical. 
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Figure 3.14: Box plots of Antimicrobial Homogeneity Index 2002-2005 
 
The AHIGN distribution is negatively skewed for all four years, as shown on Figure 3.15. 
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Figure 3.15: Box plots of Antimicrobial Homogeneity Index Gram Negative 2002-
2005 
 
 The Hospitals that show up as outliers in the box plots for the diversity indices are 
Hospital 11 (SID 2003, SWID 2002-2005), Hospital 36 (SID 2002, SWID 2002), Hospital 
15 (SID 2004-2005, SIDGN 2003-2005, SWID 2002 & 2004-2005, SWIDGN 2002-2003 
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& 2005), Hospital 6 (SIDGN 2002-2004, SWIDGN 2003-2004, AHIGN 2004), Hospital 
42 (SIDGN 2005, SWIDGN 2005, AHIGN 2005), Hospital 16 (AHIGN 2005), and 
Hospital 38 (SIDGN 2005).  Table 3.4 shows the mean and median proportions of 
resistance for the outlier hospitals, and mean and median proportions of resistance for the 
remainder hospitals for the years 2002 and 2003.  Results for 2004 and 2005 are very 
similar to 2002 and 2003 and are not reported here.  Even though most of these hospitals 
had unusually low diversity index values, the mean and median proportions of resistance 
for these hospitals are smaller than the mean and median for the rest of the hospitals.  This 
result was unexpected.  
 
Table 3.4:  Median and mean proportions of resistance for outlier diversity indices  
 
Bug-Year 
Mean of 
outliers 
Median of 
outliers 
Mean 
without 
outliers 
Median 
without 
outliers 
CERKS-2002 0.04 0.02 0.06 0.03 
CERPA-2002 0.19 0.11 0.22 0.22 
CPRPA-2002 0.15 0.17 0.22 0.22 
FQREC-2002 0.03 0.04 0.09 0.08 
FQRPA-2002 0.30 0.28 0.36 0.39 
MRSA-2002 0.39 0.44 0.43 0.46 
PTRPA-2002 0.11 0.08 0.13 0.12 
CERKS-2003 0.03 0.02 0.06 0.03 
CERPA-2003 0.14 0.10 0.23 0.21 
CPRPA-2003 0.16 0.21 0.21 0.21 
FQREC-2003 0.07 0.07 0.12 0.09 
FQRPA-2003 0.27 0.28 0.36 0.40 
MRSA-2003 0.42 0.43 0.49 0.50 
PTRPA-2003 0.09 0.08 0.15 0.15 
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3.4 Pearson Correlations for the Diversity Indices 
Correlation coefficients for the indices were computed for the years 2002 (Table 
3.5), 2003 (Table 3.6), 2004 (Table 3.7), and 2005 (Table 3.8). Indices for all drugs (SID, 
SWID, and AHI) have strong positive correlations between them, as do the indices for 
Gram-negative drugs (SIDGN, SWIDGN, AHIGN). The correlations of indices between 
all drugs and Gram-negative drugs range from weak (0.03 for AHI and AHIGN in 2002) to 
moderate (0.55 for SWID and AHIGN in 2003). 
 
 
Table 3.5 Diversity indices correlations for the year 2002 (N=31) 
 
Diversity Index SID SIDGN SWID SWIDGN AHI 
SID —     
SIDGN 0.23 —    
SWID 0.97 0.25 —   
SWIDGN 0.34 0.97 0.37 —  
AHI 0.80 0.08 0.85 0.18 — 
AHIGN 0.28 0.94 0.28 0.96 0.03 
 
 
Table 3.6  Diversity indices correlations for the year 2003 (N=35) 
 
Diversity Index SID SIDGN SWID SWIDGN AHI 
SID —     
SIDGN 0.44 —    
SWID 0.97 0.47 —   
SWIDGN 0.51 0.97 0.54 —  
AHI 0.79 0.43 0.87 0.48 — 
AHIGN 0.54 0.92 0.55 0.96 0.46 
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Table 3.7 Diversity indices correlations for the year 2004 (N=38) 
 
Diversity Index SID SIDGN SWID SWIDGN AHI 
SID —     
SIDGN 0.33 —    
SWID 0.97 0.36 —   
SWIDGN 0.39 0.98 0.42 —  
AHI 0.76 0.21 0.85 0.26 — 
AHIGN 0.31 0.96 0.34 0.97 0.18 
 
 
Table 3.8 Diversity indices correlations for the year 2005 (N=37) 
 
Diversity Index SID SIDGN SWID SWIDGN AHI 
SID —     
SIDGN 0.51 —    
SWID 0.97 0.50 —   
SWIDGN 0.52 0.98 0.53 —  
AHI 0.79 0.27 0.87 0.32 — 
AHIGN 0.49 0.92 0.47 0.95 0.26 
 
The scatterplot in Figure 3.16 for the Diversity Indices for the year 2002 shows a 
strong linear relationship between pairs of general indices and between pairs of Gram-
negative indices. All correlations between the proportion of resistance for MRSA and the 
diversity indices for the year 2002 were relatively weak. Scatterplots of indices for the 
years 2003, 2004, and 2005, and proportions of resistance for the other seven bacteria 
show a similar trend as that of MRSA 2002. 
 The correlation coefficients between the diversity indices and the proportions of 
resistance of MRSA from the year 2002 to 2005 are displayed in Table 3.9.  The 
correlation coefficients of near zero indicate almost no linear relationship between MRSA 
and the diversity indices, while those correlation coefficients with magnitudes between 
±0.1 and ±0.36 show a weak linear relationship between MRSA and the diversity indices. 
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Figure 3.16: Scatterplot of Diversity Indices in 2002 
 
 
 
Table 3.9 Correlation coefficients between Proportions of resistance for MRSA and 
Diversity Indices 
 
 MRSA 
2002 
MRSA 
2003 
MRSA 
2004 
MRSA 
2005 
SID 0.27 0.15 0.10   -0.08   
SIDGN -0.10 0.00 0.08   0.06    
SWID 0.36 0.17 0.01   -0.08   
SWIDGN -0.00 0.09 0.02  0.06    
AHI 0.18 0.01 -0.23    -0.21  
AHIGN -0.04 0.06 0.03  -0.10  
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Chapter 4: Results and Discussion 
 
 
4.1 Least Squares Multiple Regression Results 
Multiple linear regression models were constructed to examine the association 
between measures of diversity and the proportion of resistant isolates of various bacteria 
within a given year.  The findings of the models are presented in Table 4.1. Coefficients 
that are statistically significant at α=0.05 level are bolded.  
The analysis suggests that there is significant positive association (possibly due to 
multicollinearity) between MRSA isolates and SWIDGN in 2004, significant negative 
association between MRSA isolates and AHIGN in 2004, and significant negative 
association between MRSA isolates and AHIGN in 2005. This implies that higher levels of 
SWIDGN in 2004 were associated with higher proportions of MRSA, higher levels of 
AHIGN in 2004 were associated with lower proportions of MRSA, and finally higher 
levels of AHIGN in 2005 were associated with lower proportions of MRSA isolates.  
These results are different from the correlation results presented in Table 3.9, likely due to 
multicollinearity when considering numerous variables together (discussed in section 4.2). 
There are sporadic significant relationships noted for diversity measures and the 
proportions of various resistant FQRPA isolates. In 2002 the analysis found that diversity 
measures SIDGN, SWIDGN, AHI, and AHIGN based on all fourteen of the antibiotic 
drugs and classes were significantly associated with the proportion of FQRPA isolates.  In 
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2003 SIDGN and SWIDGN were significantly associated with FQRPA, and in 2005 
SIDGN, SWIDGN, and AHI were significant in predicting the proportion of FQRPA. 
Conversely, in 2004 there was no association found between any of the diversity measures 
and the proportion of FQRPA. 
The six diversity measures based on all fourteen of the antibiotic drugs and classes 
showed no significant associations with proportions of PTRPA, FQREC, CERES, or 
CERPA isolates.  All the coefficients were not significant as well as the overall F-value. 
The only significant association between the proportion of CERKS isolates and the 
diversity measures was in 2004, where SID, SWID, and AHI were significant, and in 2005 
where SIDGN was significant. 
There were some significant relationships noted for diversity measures and the 
proportions of various resistant CPRPA isolates. In 2002 the analysis found that diversity 
measures SWID, SWIDGN, and AHI based on all fourteen of the antibiotic drugs and 
classes were significantly associated with the proportion of CPRPA isolates.  In 2004 
SIDGN and SWIDGN were significantly associated with CPRPA. There were no 
significant associations found between any of the diversity measures and the proportion of 
CPRPA isolates in 2003 and 2005. 
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Table 4.1.  Summary table of multiple linear regression coefficients for diversity and 
proportion of resistant isolates by year (values in bold are significant at α=0.05). 
 
 
Bacteria-Year 
F-value 
(p-value) 
SID       
(p-value) 
SIDGN 
(p-value) 
SWID    
(p-value) 
SWIDGN 
(p-value) 
AHI      
(p-value) 
AHIGN 
(p-value) 
MRSA-2002 
1.76 
(0.179) 
-13.10 
(0.19) 
-2.19 
(0.12) 
3.36 
(0.07) 
0.73 
(0.45) 
-0.79 
(0.45) 
0.29 
(0.78) 
MRSA-2003 
1.36 
(0.278) 
-8.29 
(0.28) 
-3.05 
(0.08) 
2.52 
(0.16) 
2.09 
(0.08) 
-1.57 
(0.15) 
-0.95 
(0.37) 
MRSA-2004 
3.12 
(0.024) 
7.56 
 (0.19) 
-1.97 
(0.11) 
-0.98 
(0.47) 
2.38 
(0.01) 
-1.13 
(0.10) 
-2.02 
(0.01) 
MRSA-2005 
1.46 
(0.262) 
-0.45 
(0.96) 
-0.85 
(0.73) 
0.80 
(0.73) 
2.21 
(0.14) 
-2.20 
(0.15) 
-2.41 
(0.02) 
PTRPA-2002 
2.76 
(0.064) 
-2.27 
(0.63) 
0.33 
(0.65) 
1.26 
(0.13) 
0.46 
(0.32) 
-0.72 
(0.18) 
-1.26 
(0.07) 
PTRPA-2003 
0.86 
(0.539) 
-4.06 
(0.44) 
0.22 
(0.85) 
1.36 
(0.26) 
-0.02 
(0.97) 
-1.03 
(0.17) 
0.12 
(0.87) 
PTRPA-2004 
0.57 
(0.748) 2.98 (0.69) 
0.28 
(0.82) 
-0.30 
(0.86) 
0.25 
(0.74) 
-0.40 
(0.57) 
-0.34 
(0.57) 
PTRPA-2005 
1.11 
(0.406) 
-2.16 
(0.69) 
-2.63 
(0.08) 
0.58 
(0.67) 
1.49 
(0.08) 
-0.30 
(0.72) 
0.01 
(0.98) 
FQRPA-2002 
5.12 
(0.0056) 
-2.20 
(0.73) 
-2.18 
(0.03) 
1.58 
(0.18) 
2.56 
(<0.01) 
-2.35 
(<0.01) 
-2.31 
(<0.01) 
FQRPA-2003 
3.84 
(0.011) 
-0.59 
(0.92) 
-4.51 
(<0.01) 
1.33 
(0.37) 
3.16 
(<0.01) 
-1.63 
(0.07) 
-1.29 
(0.15) 
FQRPA-2004 
2.14 
(0.09) 
6.04  
(0.42) 
-2.01 
(0.21) 
-0.17 
(0.92) 
0.88 
(0.43) 
-1.29 
(0.16) 
0.47 
(0.63) 
FQRPA-2005 
5.86 
(0.0031) 
-4.37 
(0.33) 
-2.83 
(0.03) 
1.79 
(0.12) 
1.54 
(0.04) 
-2.43 
(<0.01) 
0.45 
(0.33) 
CERPA-2002 
1.55 
(0.275) 
19.09 
(0.18) 
-2.67 
(0.28) 
-2.36 
(0.32) 
3.53 
(0.05) 
-1.47 
(0.27) 
-3.58 
(0.06) 
CERPA-2003 
1.93 
(0.164) 
23.41 
(0.03) 
-2.32 
(0.33) 
-3.85 
(0.09) 
0.57 
(0.76) 
0.10 
(0.93) 
-0.60 
(0.74) 
CERPA-2004 
1.71 
(0.182) 
11.21 
(0.18) 
1.02 
(0.59) 
-2.18 
(0.26) 
0.04 
(0.97) 
1.27 
(0.19) 
-0.84 
(0.29) 
CERPA-2005 
1.96 
(0.146) 
-2.98 
(0.63) 
-3.12 
(0.07) 
1.53 
(0.32) 
1.84 
(0.06) 
-1.06 
(0.29) 
-0.26 
(0.69) 
CPRPA-2002 
3.96 
(0.0204) 
-7.23 
(0.21) 
-1.28 
(0.16) 
2.57 
(0.03) 
1.59 
(0.04) 
-1.93 
(0.01) 
-1.53 
(0.09) 
CPRPA-2003 
1.61 
(0.193) 
5.99 
 (0.34) 
-2.58 
(0.07) 
-0.56 
(0.70) 
1.59 
(0.10) 
-0.28 
(0.74) 
-0.59 
(0.49) 
CPRPA-2004 
3.86 
(0.010) 
5.82 
 (0.30) 
-4.28 
(<0.01) 
-0.67 
(0.61) 
2.45 
(<0.01) 
-0.23 
(0.74) 
-0.38 
(0.49) 
CPRPA-2005 
1.09 
(0.417) 
2.44 
 (0.79) 
-3.58 
(0.27) 
0.91 
(0.68) 
2.22 
(0.19) 
-2.03 
(0.21) 
-0.63 
(0.51) 
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CERES-2002 
0.95 
(0.50) 
-12.30 
(0.47) 
2.16 
(0.45) 
3.63 
(0.22) 
0.52 
(0.76) 
-2.33 
(0.17) 
-2.84 
(0.20) 
CERES-2003 
0.69 
(0.66) 
-7.67 
(0.48) 
3.08 
(0.25) 
2.17 
(0.39) 
-0.82 
(0.65) 
-1.12 
(0.50) 
-1.28 
(0.41) 
CERES-2004 
0.57 
(0.75) 
-8.04 
(0.41) 
-0.68 
(0.69) 
1.95 
(0.36) 
0.96 
(0.38) 
-0.40 
(0.68) 
-1.06 
(0.24) 
CERES-2005 
0.89 
(0.54) 
-14.46 
(0.31) 
-2.27 
(0.45) 
4.18 
(0.18) 
1.91 
(0.29) 
-2.58 
(0.14) 
-1.14 
(0.38) 
CERKS-2002 
1.27 
(0.36) 
-8.15 
(0.36) 
0.73 
(0.62) 
2.49 
(0.11) 
-0.29 
(0.76) 
-1.19 
(0.17) 
-0.58 
(0.60) 
CERKS-2003 
1.30 
(0.32) 
-9.34 
(0.16) 
-0.17 
(0.91) 
2.71 
(0.08) 
0.49 
(0.63) 
-1.82 
(0.06) 
-0.96 
(0.29) 
CERKS-2004 
2.82 
(0.04) 
-24.91 
(0.02) 
-2.70 
(0.22) 
7.17 
(<0.01) 
2.02 
(0.13) 
-3.49 
(<0.01) 
-1.77 
(0.06) 
CERKS-2005 
1.83 
(0.17) 
19.20 
(0.18) 
8.69 
(0.04) 
-4.72 
(0.18) 
-4.45 
(0.07) 
3.70 
(0.10) 
-0.47 
(0.76) 
FQREC-2002 
1.60 
(0.25) 
-7.17 
(0.19) 
0.19 
(0.82) 
1.81 
(0.06) 
0.19 
(0.74) 
-0.68 
(0.20) 
-0.57 
(0.40) 
FQREC-2003 
0.70 
(0.65) 
-7.33 
(0.26) 
0.13 
(0.93) 
2.08 
(0.18) 
0.43 
(0.69) 
-1.55 
(0.13) 
-0.74 
(0.42) 
FQREC-2004 
1.21 
(0.35) 
-5.14 
(0.50) 
-1.78 
(0.91) 
1.99 
(0.27) 
0.77 
(0.46) 
-1.56 
(0.09) 
-1.03 
(0.16) 
FQREC-2005 
0.74 
(0.62) 
-7.77 
(0.27) 
-1.79 
(0.33) 
2.30 
(0.19) 
1.18 
(0.27) 
-1.61 
(0.15) 
-0.30 
(0.67) 
 
 
4.2 Multicollinearity Results  
Variance Inflation Factors, Eigenvalues, and Condition Indices 
In the VIF analysis, there are numerous VIF values as shown in Table 4.2 that are 
greater than the cut-off point value of 10.  These values indicate that there are severe 
multicollinearity problems within the various measures of diversity. The variance 
proportions and the eigenvalues indicate that there are severe dependencies throughout the 
study period among the measures of diversity based on all drugs (SID, SWID, and AHI). 
Likewise, severe dependencies exist among the measures of diversity based on Gram-
negative drugs (SIDGN, SWIDGN, and AHIGN). There are no dependencies between any 
of the diversity indices based on Gram-negative drugs and all drugs. This means that there 
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are too many predictors in the model and there may be a need for at least one general index 
plus at least one Gram-negative index in the model.  
Table 4.2.  Summary table of VIFs for diversity and proportion of resistant isolates 
by year. 
 
Bacteria-Year SID       SIDGN  SWID     SWIDGN  AHI       AHIGN  
MRSA-2002 16.92 12.42 16.98 33.08 2.66 25.96 
MRSA-2003 26.70 12.66 39.51 28.26 4.62 12.80 
MRSA-2004 27.84 16.69 43.76 39.46 4.86 17.78 
MRSA-2005 26.33 26.03 39.55 35.08 4.78 8.51 
PTRPA-2002 9.02 23.08 10.44 20.07 2.77 26.07 
PTRPA-2003 25.40 23.39 39.51 40.64 5.24 13.10 
PTRPA-2004 49.29 23.77 74.10 37.53 4.79 10.17 
PTRPA-2005 30.53 18.48 36.49 23.43 3.95 14.24 
FQRPA-2002 21.71 19.84 24.02 36.91 3.39 21.81 
FQRPA-2003 26.90 25.41 43.37 41.84 5.79 12.49 
FQRPA-2004 31.61 26.62 52.32 51.97 5.48 15.76 
FQRPA-2005 26.33 26.03 39.55 35.08 4.78 8.51 
CERPA-2002 41.68 18.29 32.19 42.67 4.38 41.26 
CERPA-2003 33.40 9.62 46.70 24.00 5.02 12.26 
CERPA-2004 34.52 35.72 55.59 46.04 5.75 9.08 
CERPA-2005 24.64 25.53 36.06 34.23 4.26 8.46 
CPRPA-2002 20.55 12.22 20.57 29.22 2.84 26.91 
CPRPA-2003 29.29 24.43 46.72 41.61 5.83 13.11 
CPRPA-2004 34.36 29.50 56.41 46.37 6.53 10.44 
CPRPA-2005 26.59 37.00 39.49 44.30 5.58 7.58 
CERES-2002 43.71 19.75 34.13 34.09 4.04 38.80 
CERES-2003 14.13 9.85 26.29 18.40 7.12 10.60 
CERES-2004 33.19 21.30 49.17 33.22 4.45 9.14 
CERES-2005 31.89 25.23 22.72 36.68 3.57 37.20 
CERKS-2002 19.71 134.36 11.72 51.58 5.92 58.97 
CERKS-2003 39.94 9.50 53.48 19.52 4.59 11.19 
CERKS-2004 30.57 16.19 42.45 23.30 4.64 8.83 
CERKS-2005 40.87 25.21 50.07 42.84 5.34 16.49 
FQREC-2002 37.90 31.83 31.78 42.49 4.03 30.98 
FQREC-2003 32.70 32.67 53.66 62.48 7.41 14.67 
FQREC-2004 34.47 30.97 54.57 44.07 5.64 8.91 
FQREC-2005 21.31 32.50 26.96 37.60 3.68 7.80 
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Table 4.3 illustrates sample multicollinearity output for FQREC in 2002, showing 
large VIFs, one small eigenvalue (based on the large condition index value), and variance 
proportions. The three large variance proportions for SID02 (0.851), SWID02 (0.797), and 
AHI02 (0.798) indicate that there may be a strong linear dependency among these three 
measures. 
 
Table 4.3 Sample multicollinearity diagnostics for FQREC   
 
Variable VIF Eigenvalue CI Proportion of Variation 
    SID SIDGN SWID SWIDGN AHI AHIGN 
SID 37.90 3.994 1.000 0.001 0.001 0.001 0.001 0.005 0.001 
SIDGN 31.83 1.642 1.559 0.002 0.003 0.003 0.001 0.046 0.003 
SWID 31.78 0.279 3.777 0.019 0.003 0.018 0.004 0.497 0.001 
SWIDGN 42.49 0.049 8.953 0.105 0.008 0.178 0.146 0.150 0.109 
AHI 4.033 0.025 12.66 0.022 0.705 0.002 0.030 0.103 0.488 
AHIGN 30.98 0.008 41.37 0.851 0.281 0.797 0.317 0.798 0.398 
 
 
4.3 Residual Plots 
If the model is appropriate, a plot of residuals versus iyˆ should be centered at 0 and 
scattered about the line at 0. The absolute residuals should be close to 0. The residual plots 
shown in Figure 4.1 to Figure 4.8 indicate that most, if not all, of the models are not 
appropriate. The pattern of scatter indicates that least squares multiple regressions may not 
be appropriate, and a logit transformation of the response variable or logistic regression 
should be used instead of linear regression. 
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MRSA: methicillin-resistant Staphylococcus aureus    
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Figure 4.1  Residual plots of proportion of MRSA  
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CERPA: cephalosporin-resistant Pseudomonas aeruginosa 
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Figure 4.2  Residual plots of proportion of CERPA  
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CERES: cephalosporin-resistant Enterobacter species 
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Figure 4.3  Residual plots of proportion of CERES  
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CERKS: cephalosporin-resistant Klebsiella species:  
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Figure 4.4  Residual plots of proportion of CERKS  
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CPRPA: carbapenem-resistant Pseudomonas aeruginosa  
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Figure 4.5  Residual plots of proportion of CPRPA  
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FQREC: fluoroquinolone-resistant Escherichia coli 
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Figure 4.6  Residual plots of proportion of FQREC  
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FQRPA: fluoroquinolone-resistant Pseudomonas aeruginosa  
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Figure 4.7  Residual plots of proportion of FQRPA  
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PTRPA: piperacillin-tazobactam-resistant Pseudomonas aeruginosa:. 
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Figure 4.8  Residual plots of proportion of PTRPA  
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4.4 Model Selection 
 Using the model selection criteria of R-square, stepwise selection, backward 
elimination, and forward selection, the best model was chosen for each of the “Bacteria-
year” combinations as shown in Table 4.4.  Of the variables selected for entrance into the 
model by the variable selection routines (using the specified significance level to enter), 
there were no significant variables (at =.05) remaining in the final models for PTRPA-
2003, PTRPA-2004, CPRPA-2003, CERES-2003, CERES-2004, CERKS-2003, CERKS-
2005, and FQREC-2004.  For CPRPA-2005 and FQREC-2003, no independent variable 
met any of the model selection criteria for entrance into the model. 
 
Table 4.4.  Summary table for best model of multiple linear regression coefficients for 
diversity and proportion of resistant isolates by year. 
 
Bacteria-Year 
F-value 
(p-value) 
SID       
(p-value) 
SIDGN 
(p-value) 
SWID    
(p-value) 
SWIDGN 
(p-value) 
AHI      
(p-value) 
AHIGN 
(p-value) 
MRSA-2002 
4.86 
(0.021) 
-16.69 
(0.06)  
3.81 
(0.02)    
MRSA-2003 
2.36 
(0.116)  
-3.43 
(0.046)  
1.84 
(0.04)   
MRSA-2004 
3.57 
(0.022) 3.51 (0.06)   
1.38 
(0.047) 
-1.34 
(0.01) 
-2.01 
(0.03) 
MRSA-2005 
3.90 
(0.04)    
2.76 
(0.02)  
-3.41 
(0.01) 
PTRPA-2002 
5.06 
(0.02) 
-8.08 
(0.07)  
2.15 
(0.01)    
PTRPA-2003 
3.23 
(0.08)      
0.34 
(0.08) 
PTRPA-2004 
2.34 
(0.14)  
0.35 
(0.14)     
PTRPA-2005 
3.82 
(0.04)  
-2.53 
(0.06)  
1.50 
(0.03)   
FQRPA-2002 
6.50 
(<0.01)  
-2.20 
(0.02) 
1.21 
(0.01) 
2.63 
(<0.01) 
-2.38 
(<0.01) 
-2.41 
(<0.01) 
FQRPA-2003 
5.12 
(<0.01)  
-4.27 
(<0.01) 
1.07 
(0.03) 
2.29 
(<0.01) 
-1.38 
(0.07)  
FQRPA-2004 
5.18 
(0.01) 
6.20 
(<0.01)    
-1.38 
(0.02)  
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FQRPA-2005 
8.54 
(<0.01)  
-2.93 
(0.02) 
0.82 
(0.04) 
1.92 
(<0.01) 
-2.24 
(<0.01)  
CERPA-2002 
2.91 
(0.08) 
35.12 
(0.03) 
-2.92 
(<0.01) 
-4.35 
(0.07)  
-3.15 
(0.04)  
CERPA-2003 
4.80 
(0.02) 
23.18 
(<0.01) 
-2.00 
(0.02) 
-3.77 
(0.01)    
CERPA-2004 
6.57 
(0.02) 
3.38 
(0.02)      
CERPA-2005 
6.14 
(0.02)   
0.63 
(0.02)    
CPRPA-2002 
4.12 
(0.03)   
1.46 
(<0.01)  
-1.97 
(0.02) 
-0.51 
(0.04) 
CPRPA-2003 
3.61 
(0.07) 
2.21 
 (0.07)      
CPRPA-2004 
7.56 
(<0.01) 
2.06 
 (0.07) 
-4.37 
(<0.01)  
2.18 
(<0.01)   
CPRPA-2005 
none 
none      
CERES-2002 
3.50 
(0.05) 
11.74 
(0.03)   
-1.51 
(0.01) 
-4.18 
(0.01)  
CERES-2003 
2.63 
(0.12)      
-0.88 
(0.12) 
CERES-2004 
1.45 
(0.24)   
0.33 
(0.24)    
CERES-2005 
1.66 
(0.23) 
-32.94 
(0.06)  
5.43 
(0.07) 
4.17 
(0.04)  
-4.40 
(0.04) 
CERKS-2002 
3.82 
(0.04)  
-1.17 
(0.01) 
1.90 
(0.02)  
-2.21 
(0.02)  
CERKS-2003 
2.91 
(0.10)  
-0.90 
(0.10)     
CERKS-2004 
3.32 
(0.03) 
-22.16 
(0.03)  
6.64 
(<0.01)  
-3.06 
(0.02) 
-0.88 
(0.047) 
CERKS-2005 
2.97 
(0.10)   
0.35 
(0.10)    
FQREC-2002 
5.01 
(0.02)   
0.58 
(<0.01) 
0.49 
(0.03) 
-0.59 
(0.07) 
-1.01 
(<0.01) 
FQREC-2003 
none 
      
FQREC-2004 
1.84 
(0.16)   
0.82 
(0.08) 
0.67 
(0.16) 
-1.19 
(0.08) 
-0.95 
(0.17) 
FQREC-2005 
2.14 
(0.14) 
-16.41 
(0.04)  
3.76 
(0.02)  
-1.65 
(0.07)  
 
 
One-variable model 
Using model selection criteria R-square and mean square error, one best 
prescription practice or diversity index that could explain the proportion of resistance for 
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each “Bacteria-year” was selected. The model selected for each of the four years had the 
highest R-square and smallest mean square error.  As shown in Table 4.5, there is no one 
single prescription practice or diversity index that fits all the bacteria.  It should also be 
noted that none of the single variables selected were significant. 
Table 4.5.  Summary table for best one-variable model 
 
Bacteria-Year n 
One-variable 
model: Ordinary 
Least squares 
MRSA-2002 21 SWID 
MRSA-2003 27 SWID 
MRSA-2004 28 AHI 
MRSA-2005 21 AHI 
CERES-2002 16 SWIDGN 
CERES-2003 20 AHIGN 
CERES-2004 23 SWID 
CERES-2005 16 SWID 
CERKS-2002 16 SWIDGN 
CERKS-2003 20 SIDGN 
CERKS-2004 24 SWID 
CERKS-2005 20 SWID 
CPRPA-2002 20 SID 
CPRPA-2003 28 SID 
CPRPA-2004 28 SID 
CPRPA-2005 20 SID 
CERPA-2002 15 SIDGN 
CERPA-2003 19 SID 
CERPA-2004 23 SID 
CERPA-2005 20 SWID 
FQREC-2002 16 SWID 
FQREC-2003 21 SWIDGN 
FQREC-2004 24 SID 
FQREC-2005 20 SWIDGN 
FQRPA-2002 21 SWID 
FQRPA-2003 26 SID 
FQRPA-2004 28 SID 
FQRPA-2005 21 AHIGN 
PTRPA-2002 19 SWID 
PTRPA-2003 25 AHIGN 
PTRPA-2004 27 SIDGN 
PTRPA-2005 20 SWIDGN 
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4.5 Logistic Regression Results 
Since ordinary least squares regression failed to find an appropriate model that can 
explain the relationship between the diversity indices and the proportion of resistance, a 
logistic regression was performed. The data set contained the number of successes (number 
of bacteria that were resistant to the antibiotics) and the proportion of resistance. From this, 
the number of trials (number of bacteria treated with antibiotics) was arrived at by dividing 
the number of successes by the proportion of resistance. Also, logit transformed models 
were fitted using a weighted least squares regression method.   
Before looking at the likelihood ratio statistics to determine whether at least one of 
the explanatory variables was needed in the model, a test for the appropriateness of the 
logistic regression was performed. Here “appropriate” means that the fitted logistic model 
performs as well (based on its likelihood) as a saturated model that has its number of 
parameters equal to the number of observations. If the test concludes that the model is 
“inappropriate”, this does not necessarily mean that the logistic model should not be used 
to fit the data—it is just not as good as the saturated model. The test statistic for the 
appropriateness of logistic regression is called the model deviance and the hypotheses are 
H0: logistic model appropriate  
H1: logistic model inappropriate 
If the model deviance is greater than 
2
,n p  , then the null hypothesis is rejected. For 
logistic regression to be appropriate, the model deviance needs to be less than
2
,n p  . The 
association of predicted probabilities and observed responses of the proportion of 
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resistance will also be displayed as a percentage. The results for MRSA for each of the 
four years, and the results for all classes of bacteria for all four years combined are 
displayed below. MRSA results are given for each individual year because the proportion 
of resistance for MRSA was significantly different for each subsequent year. For the rest of 
the classes of bacteria, the years were combined because the proportion of resistance did 
not differ significantly from 2002 to 2005. Also given, as a measure of predictive quality 
of the models, are percent concordant and percent discordant values. If there are two 
observations that have different responses [one ‘not resistant’ (denoted as '0') and the other 
resistant (denoted as '1')], then this pair of observations is concordant if the observation 
with the lower actual response value gives a lower predicted response as well.  They are 
discordant if the one with the lower actual response value gives a higher predicted 
response. In the results below, these values are presented as what “percent of predicted 
probabilities correctly fit/match the observed responses” and what percent do not. All other 
observations had tied predicted responses (neither concordant or discordant). 
Logistic Regression for MRSA 2002 
H0: logistic model appropriate vs. H1: logistic model inappropriate 
Model deviance = 590.32 
2
,n p  = 
2
0.05,20 7 22.36    
Since the model deviance is greater than the Chi-square critical value, the logistic 
regression model does not perform as well as the saturated model. The global likelihood 
ratio statistic is significant, which implies that at least one of the diversity indices is 
59 
 
important in predicting the proportion of bacterial resistance in 2002. Also, all coefficients 
are significant with p-values that are less than 0.001. The fitted model is  
 13.20 44.78 11.11 13.05 3.58 3.08 1.51
1
ˆ
1
SID SIDGN SWID SWIDGN AHI AHIGN
y
e
      


. 
For MRSA 2002, 52.5% of predicted probabilities correctly fit/match the observed 
responses while 41.5% of predicted probabilities do not fit/match the observed responses. 
Logit transformed model for MRSA 2002 
The overall global F-statistic is not significant with a p-value of 0.19. None of the 
coefficient estimates is significant at significance level α=0.05. However, if the 
significance level were increased to 0.1, then SIDGN and SWID both would be significant 
because they have p-values of 0.07. The fitted model is 
 13.58 45.44 10.94 13.07 3.36 2.86 1.70
1
ˆ
1
SID SIDGN SWID SWIDGN AHI AHIGN
y
e
      


. 
Logistic Regression for MRSA 2003 
H0: logistic model appropriate vs. H1: logistic model inappropriate 
Model deviance = 729.97 
2
,n p  = 
2
0.05,25 7 28.87    
Since the model deviance is greater than the Chi-square critical value, the logistic 
regression model does not perform as well as the saturated model. The global likelihood 
ratio statistic is significant, which implies that at least one of the diversity indices is 
important in predicting the proportion of bacterial resistance in 2003. Also, all coefficients, 
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except the intercept, are significant with p-values less than 0.001.  The fitted model is  
 1.83 13.82 13.82 18.12 6.13 11.43 3.72
1
ˆ
1
SID SIDGN SWID SWIDGN AHI AHIGN
y
e
      


. 
For MRSA 2003, 52.7% of predicted probabilities correctly fit/match the observed 
responses while 41.4% of predicted probabilities do not fit/match the observed responses. 
Logit transformed model for MRSA 2003 
The overall global F-statistic is not significant with a p-value of 0.16. However, 
SIDGN and SWIDGN have p-values that are less than 0.05. The fitted model is 
 1.68 13.48 17.60 6.04 11.06 3.65 4.44
1
ˆ
1
SID SIDGN SWID SWIDGN AHI AHIGN
y
e
      


. 
Logistic Regression for MRSA 2004 
H0: logistic model appropriate vs. H1: logistic model inappropriate 
Model deviance = 583.44 
2 2
, 0.05,20 7 22.36n p     
Since the model deviance is greater than the Chi-square critical value, the logistic 
regression model does not perform as well as the saturated model. The global likelihood 
ratio statistic is significant, which implies that at least one of the diversity indices is 
important in predicting the proportion of bacterial resistance in 2004. Also, all coefficients, 
except SWID, are significant with p-values that are less than 0.001.  The fitted model is  
   AHIGNAHISWIDGNSWIDSIDGNSID
e
y
18.763.446.953.154.966.2179.12
1
1
ˆ

 . 
For MRSA 2004, 52.7% of predicted probabilities correctly fit/match the observed 
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responses while 41.7% of predicted probabilities do not fit/match the observed responses. 
Logit transformed model for MRSA 2004 
The overall global F-statistic is not significant with a p-value of 0.053. However, 
SWIDGN and AHIGN have p-values that are less than 0.05. The fitted model is 
 AHIGNAHISWIDGNSWIDSIDGNSID
e
y
98.661.415.932.121.964.2038.12
1
1
ˆ

  
With a R-square of 0.43. 
 
Logistic Regression for MRSA 2005 
H0: logistic model appropriate vs. H1: logistic model inappropriate 
Model deviance = 506.17 
03.212 719,05.0
2
,    pn  
Since the model deviance is greater than the Chi-square critical value, the logistic 
regression model does not perform as well as the saturated model. The global likelihood 
ratio statistic is significant, which implies that at least one of the diversity indices is 
important in predicting the proportion of bacterial resistance in 2005. The coefficient 
estimates for SID, SIDGN, and SWID are not significant.  The fitted full model is  
   AHIGNAHISWIDGNSWIDSIDGNSID
e
y
08.387.341.220.177.049.124.0
1
1
ˆ

 . 
For MRSA 2005, 49.0% of predicted probabilities correctly fit/match the observed 
responses while 41.3% of predicted probabilities do not fit/match the observed responses. 
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Logit transformed model for MRSA 2005 
The overall global F-statistic and all the coefficient estimates are not significant. 
The fitted model is 
 AHIGNAHISWIDGNSWIDSIDGNSID
e
y
85.255.325.290.084.088.031.0
1
1
ˆ

 , 
with an R-square of 0.16 
 
Logistic Regression for MRSA, 2002-2005 combined 
H0: logistic model appropriate vs. H1: logistic model inappropriate 
Model deviance = 3084.72 
2
,n p  = 
2
0.05,91 7 106.4    
Since the model deviance is greater than the Chi-square critical value, the logistic 
regression model does not perform as well as the saturated model. However, the global 
likelihood ratio statistic is significant, which implies that at least one of the diversity 
indices is important in predicting the proportion of bacterial resistance. Also, all 
coefficients, except the intercept, are significant with p-values that are less than 0.001.  The 
fitted model is  
 0.57 8.10 8.60 5.23 7.07 6.27 4.58
1
ˆ
1
SID SIDGN SWID SWIDGN AHI AHIGN
y
e
       


. 
For MRSA 2002-2005 combined, 53.4% of predicted probabilities correctly fit/match the 
observed responses while 44.1% of predicted probabilities do not fit/match the observed 
responses. Using model selection techniques, the best model for MRSA is 
63 
 
 AHIGNAHISWID
e
y
61.041.457.399.4
1
1
ˆ

 , 
but the best one-variable model includes only SIDGN. 
Logit transformed model for MRSA, 2002-2005 combined 
The overall global F-statistic is significant with a p-value of 0.0005. The coefficient 
estimates for SID, SWID, and the intercept are not significant. The fitted full logit 
transformed model is  
 0.63 7.48 8.21 4.90 6.75 5.90 4.37
1
ˆ
1
SID SIDGN SWID SWIDGN AHI AHIGN
y
e
       


 
with a R-square of 0.22. 
The best model selected for the logit transformed model for MRSA is  
   AHIGNAHISWIDGNSWIDSIDGN
e
y
57.455.591.627.315.881.3
1
1
ˆ

 , 
but the best one-variable model includes only SID. 
Logistic Regression for CERES, 2002-2005 combined 
The full logistic model for CERES is has a significant global likelihood ratio statistic and 
all the coefficient estimates are significant. The full model also has a large model deviance 
and therefore does not perform as well as the saturated model. The fitted model is 
 AHIGNAHISWIDGNSWIDSIDGNSID
e
y
26.688.672.452.1652.281.6499.22
1
1
ˆ

 . 
This full model is also the best model when using model selection criteria. For CERES 
2002-2005 combined, 56.3% of predicted probabilities correctly fit/match the observed 
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responses while 41.3% of predicted probabilities do not fit/match the observed responses. 
The best one-variable model includes only SIDGN. 
Logit transformation for CERES, 2002-2005 combined 
The overall F-value is significant with a p-value of 0.001. The coefficient estimates for 
SIDGN and SWIDGN are significant. The full fitted logit model for CERES is 
 AHIGNAHISWIDGNSWIDSIDGNSID
e
y
73.638.615.594.1469.284.5710.20
1
1
ˆ

 . 
The best model selected for CERES is 
 AHISWIDSID
e
y
09.525.1782.7391.27
1
1
ˆ

 , 
with all variables in this model being significant. The best one-variable model includes 
only SWID. 
Logistic Regression for CERPA, 2002-2005 combined 
The full logistic model for CERPA has a significant global likelihood ratio statistic and all 
the coefficient estimates, except SWID, are significant. The full model also has a large 
model deviance and therefore does not perform as well as the saturated model. The full 
fitted logistic model for CERPA is 
 AHIGNAHISWIDGNSWIDSIDGNSID
e
y
03.688.285.693.067.538.2085.19
1
1
ˆ

  
For CERPA 2002-2005 combined, 56.2% of predicted probabilities correctly fit/match the 
observed responses while 40.8% of predicted probabilities do not fit/match the observed 
responses. The best selected logistic model for CERPA is 
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 AHIGNAHISWIDGNSIDGNSID
e
y
09.654.291.665.515.2428.21
1
1
ˆ

  
Logit transformed model for CERPA, 2002-2005 combined 
The logit transformed full model for CERPA has a significant global F-value and none of 
the coefficient estimates are significant. The full model is 
 AHIGNAHISWIDGNSWIDSIDGNSID
e
y
44.437.201.667.020.604.2212.21
1
1
ˆ

 . 
The best model selected for CERPA has only the variable SID:  
 SID
e
y
72.2267.20
1
1
ˆ

 . 
Logistic Regression for CERKS, 2002-2005 combined 
The full logistic model for CERKS has a significant global likelihood ratio statistic and all 
the coefficient estimates are significant. The full model also has a large model deviance 
and therefore does not perform as well as the saturated model. The full fitted model is 
 AHIGNAHISWIDGNSWIDSIDGNSID
e
y
36.1185.1395.810.1970.2282.2488.11
1
1
ˆ

 . 
For CERKS 2002-2005 combined, 69.8% of predicted probabilities correctly fit/match the 
observed responses while 28.2% of predicted probabilities do not fit/match the observed 
responses. The best selected logistic model for CERKS is  
 AHIGNSWIDSIDGN
e
y
88.1469.585.1041.12
1
1
ˆ

 , 
and the best one-variable model includes only SIDGN. 
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Logit transformed model for CERKS, 2002-2005 combined 
The coefficient estimates as well as the overall F-statistic for the full logit transformed 
model for CERKS are not significant. The full model is  
 AHIGNAHISWIDGNSWIDSIDGNSID
e
y
05.1141.1062.988.1820.2289.3253.5
1
1
ˆ

 . 
The best selected logit transformed model for CERKS has AHIGN and SWID variables, 
which are all significant:  
 AHIGNSWID
e
y
66.841.688.11
1
1
ˆ

 , 
and the best one-variable model includes only AHIGN. 
Logistic Regression for CPRPA, 2002-2005 combined 
The full logistic model for CPRPA has a significant global likelihood ratio statistic and all 
the coefficient estimates are significant. The full model also has a large model deviance 
and therefore does not perform as well as the saturated model. The full fitted model is 
 AHIGNAHISWIDGNSWIDSIDGNSID
e
y
96.145.696.573.785.1547.17.11
1
1
ˆ

 . 
For CPRPA 2002-2005 combined, 57.6% of predicted probabilities correctly fit/match the 
observed responses while 40.1% of predicted probabilities do not fit/match the observed 
responses. The best selected logistic model for CPRPA is  
 AHIGNAHISWIDGNSWIDSIDGN
e
y
94.136.696.541.781.1534.12
1
1
ˆ

 , 
and the best one-variable model includes only AHIGN. 
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Logit transformed model for CERPA, 2002-2005 combined 
The full logit transformed model for CPRPA has an overall significant F-value with 
insignificant coefficient estimates for SID and AHIGN. The full logit transformed model is 
 AHIGNAHISWIDGNSWIDIDGNSID
e
y
08.228.611.556.822.1404.787.8
1
1
ˆ

 . 
The best selected logit transformed model for CPRPA is  
 AHISWIDGNSWIDSIDGN
e
y
10.621.691.654.1376.11
1
1
ˆ

 , 
where all the variables are significant with p-values less than 0.01. The best one-variable 
model includes only SID. 
Logistic Regression for FQREC, 2002-2005 combined 
The full logistic model for FQREC has a significant global likelihood ratio statistic and all 
the coefficient estimates are significant. The full model also has a large model deviance 
and therefore does not perform as well as the saturated model. The full fitted model is 
 AHIGNAHISWIDGNSWIDSIDGNSID
e
y
72.421.836.457.1153.256.3201.5
1
1
ˆ

 . 
For FQREC 2002-2005 combined, 55.4% of predicted probabilities correctly fit/match the 
observed responses while 40.9% of predicted probabilities do not fit/match the observed 
responses. The best selected logistic model for FQREC is  
 AHISWIDSID
e
y
97.643.1213.3849.7
1
1
ˆ

 , 
and the best one-variable model includes only AHI. 
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Logit transformed model for FQREC, 2002-2005 combined 
The full logit transformed model for FQREC has an overall significant F-value with 
significant coefficient estimates for SWID and AHI. The full logit transformed model is 
 AHIGNAHISWIDGNSWIDSIDGNSID
e
y
45.344.871.393.1110.272.3498.5
1
1
ˆ

 . 
The best logit transformed model for FQREC is 
 AHISWIDSID
e
y
57.785.1364.4357.9
1
1
ˆ

 , 
and the best one-variable model includes only SWID. 
Logistic Regression for FQRPA, 2002-2005 combined 
The full logistic model for FQRPA has a significant global likelihood ratio statistic and all 
the coefficient estimates are significant. The full model also has a large model deviance 
and therefore does not perform as well as the saturated model. The full fitted model is 
 AHIGNAHISWIDGNSWIDSIDGNSID
e
y
87.226.774.980.608.1532.905.3
1
1
ˆ

 . 
For FQRPA 2002-2005 combined, 56.1% of predicted probabilities correctly fit/match the 
observed responses while 41.5% of predicted probabilities do not fit/match the observed 
responses. The best selected logistic model for FQRPA is  
 AHISWIDSID
e
y
50.579.733.1534.1
1
1
ˆ

 , 
and the best one-variable model includes only AHI. 
Logit transformed model for FQRPA, 2002-2005 combined 
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The full logit transformed model for FQRPA has an overall significant F-value with 
insignificant coefficient estimates for SID and AHIGN. The full logit transformed model is 
 AHIGNAHISWIDGNSWIDSIDGNSID
e
y
83.291.647.938.658.1433.820.3
1
1
ˆ

 . 
The best logit transformed model for FQRPA is 
 AHISWID
e
y
39.434.462.7
1
1
ˆ

 , 
and the best one-variable model includes only SID. 
Logistic Regression for PTRPA, 2002-2005 combined 
The full logistic model for PTRPA has a significant global likelihood ratio statistic and all 
the coefficient estimates are significant except AHIGN. The full model also has a large 
model deviance and therefore does not perform as well as the saturated model. The full 
fitted model is 
 AHIGNAHISWIDGNSWIDSIDGNSID
e
y
74.027.459.242.1230.368.4266.9
1
1
ˆ

 . 
For PTRPA 2002-2005 combined, 54.4% of predicted probabilities correctly fit/match the 
observed responses while 41.6% of predicted probabilities do not fit/match the observed 
responses. The best selected logistic model for PTRPA is  
 AHISWIDSID
e
y
07.415.1334.4476.9
1
1
ˆ

 , 
and the best one-variable model includes only AHI. 
Logit transformed model for PTRPA, 2002-2005 combined 
70 
 
For the full logit transformed model for PTRPA below, the overall F-value is significant, 
only SID and SWID are significant individually: 
 AHIGNAHISWIDGNSWIDSIDGNSID
e
y
63.013.372.124.1091.123.3462.6
1
1
ˆ

 . 
The best selected logit transformed model for PTRPA includes SWID and SID, and their 
coefficient estimates are significant: 
 SWIDSID
e
y
68.777.2628.4
1
1
ˆ

 . 
The best one-variable model includes only SID. 
One-variable models 
The best one-variable models from logistic regression and logit transformed models 
are displayed in Table 4.6. All of these one-variable models are significant in predicting 
the proportion of resistant isolates. 
 
Table 4.6.  Logistic Regression summary table for best one-variable model 
 
Bacteria-Year n 
Logistic 
Regression 
Weighted 
Least Squares  
MRSA-2002 21 AHI SWID 
MRSA-2003 27 AHI SWID 
MRSA-2004 28 AHI AHI 
MRSA-2005 21 AHI AHI 
MRSA-All 91 SIDGN SID 
CERES-All 75 SIDGN SWID 
CERKS-All 73 SIDGN AHIGN 
CPRPA-All 92 AHIGN SID 
CERPA-All 92 AHIGN SID 
FQREC-All 75 AHI SWID 
FQRPA-All 90 AHI SID 
PTRPA-All 88 AHI SID 
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Chapter 5: Conclusions 
 
MRSA continues to have the highest rates of resistance among the organisms 
examined and has increased significantly since 2002. Trends in other proportions of 
resistance appear to be stable or declining. There are situations where the overall F-value, 
which indicates that at least one of the prescription practices or diversity indices is 
important in predicting the proportion of resistance, is not significant while at least one of 
the partial t-tests is significant. This does not happen quite often, but one possible 
explanation why it happened in this data set is that there is very little variation in the data 
set, so the partial t-tests can be significant because with only 1 degree of freedom it is not 
required that much variation be explained. The ordinary least squares regression procedure 
did not find one single prescription practice or diversity index that fits all the bacteria for 
each of the four years. However, the diversity indices SWID and SID did occur more often 
than the other measures in these single variable models, giving possible evidence that these 
two indices may be the ‘better’ measures of diversity in this specific application.  
A logistic regression model and a logit transformed model (using weighted least 
squares regression) were fitted for each of the four years for MRSA, and for all the years 
combined for the eight classes of bacteria in the study. The logistic regression results for 
the eight classes of bacteria in this study were consistent. That is, for a given bacteria, the 
coefficient estimates for the full logistic regression model and the full logit transformed 
model were similar. Except for CERKS, the overall F-values for the logit transformed 
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models for each index were significant when combining the four years together. A test for 
the appropriateness of the logistic model showed that the fitted logistic regression model 
did not perform as well as a saturated model for modeling the proportion of resistance 
versus the diversity indices for each of the four years and for all the data sets combined. 
This outcome was surprising because the global likelihood ratio statistics for the models 
for all the years combined showed that at least one of the diversity indices was necessary in 
predicting the proportion of resistance. In fact, when all the data sets for the four years 
were combined (and for MRSA for each year individually), there was a single significant 
diversity index for each type of bacteria that best explained the proportion of resistance, as 
displayed on Table 4.6. For logistic regression, AHI was the most commonly selected 
index, followed by SIDGN and AHIGN. For the logit transformation, there was a variety 
of indices chosen for the one-variable models. 
Though this data set contains information for four years, there is considerable 
variation in the number of hospitals that reported data in each of the years. Hospitals 
entering and leaving the study at different times may have introduced bias in that they may 
have had greatly different characteristics with regards to antibiotic use and resistance.  
Elimination of hospitals for which we could not identify proportions of resistance in all 
four years of the study period would have greatly reduced the sample size. Also, the 
health-systems in this study were from teaching institutions and may not be generalizable 
to other hospitals or the general population of U.S. health-systems. 
Since no diversity index was found to be the “best” in terms of explaining 
resistance rates in a global fashion, a future study could look at coming up with a new 
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measure of diversity that may combine some of the characteristics of those in this study.  
Also, further work could investigate individual hospitals, especially those that have been 
identified as outliers in this project. There may be certain practices occurring at individual 
hospitals that better explain some of the measures of resistance seen in this current study. 
Also, no hospitals were removed from the data set when conducting the analyses of this 
preliminary study. Identification of hospitals with ‘suspect’ values and appropriate removal 
of these observations from the data set could have an important effect on the results of this 
study. In particular, there may be improvement in the performance of the logistic 
regression models in terms of fit (lowering the model deviance) and prediction (increasing 
the percent concordant values, which were relative low for many of the models). 
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List of drugs used in the study 
Classified into fourteen different classes:  
1. anti-staphylococcal penicillins (nafcillin, oxacillin, dicloxacillin),  
2. 1st & 2nd generation cephalosporins (cefazolin, cefaclor, cefuroxime, cefoxitin, 
cefotetan, cefixime),  
3. 3rd/4th generation cephalosporins (ceftriaxone, cefpodoxime, ceftazidime, 
ceftidoren, cefdinir, cefprozil, cefotaxime, cefepime, and aztreonam),  
4. aminoglycosides (gentamicin, tobramycin, amikacin),  
5. beta-lactam/beta-lactamase inhibitors (ampicillin-sulbactam, piperacillin-
tazobactam, amoxicillin-clavulanate, ticarcillin-clavulanate),  
6. carbapenems (meropenem, imipenem, ertapenem),  
7. macrolides (erythromycin, clarithromycin, azitrhomycin),  
8. fluoroquinolones (gatifloxacin, moxifloxacin, levofloxacin, ciprofloxacin),  
9. sulfamethoxazole/trimethoprim, 
10.  metronidazole,  
11.  clindamycin, 
12.  quinupristin/dalfopristin, 
13.  vancomycin,  
14.  linezolid. 
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